Carboplatin, nab-paclitaxel plus atezolizumab in IMpower 130 trial: new weapons beyond controversies
Transl Cancer Res
.
2019 Dec;8(8):E18-E23.
doi: 10.21037/tcr.2019.12.69.
Authors
Andrea De Giglio
1
,
Giacomo Nuvola
1
,
Filippo Gustavo Dall'Olio
1
Affiliation
1
Department of Specialized, Experimental and Diagnostic Medicine, S.Orsola-Malpighi University Hospital, Alma Mater Studiorum University of Bologna, Bologna, Italy.
PMID:
35117058
PMCID:
PMC8798162
DOI:
10.21037/tcr.2019.12.69
No abstract available
Publication types
Editorial
Comment